451 related articles for article (PubMed ID: 12224070)
41. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.
Krantz DA; Hallahan TW; Macri VJ; Macri JN
Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986
[TBL] [Abstract][Full Text] [Related]
42. Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.
Spencer K; Liao AW; Ong CY; Geerts L; Nicolaides KH
Prenat Diagn; 2001 Jun; 21(6):441-4. PubMed ID: 11438945
[TBL] [Abstract][Full Text] [Related]
43. First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters.
Leung TY; Chan LW; Leung TN; Fung TY; Sahota DS; Lau TK
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):156-61. PubMed ID: 16435317
[TBL] [Abstract][Full Text] [Related]
44. Early first-trimester free beta-hCG and PAPP-A serum distributions in monochorionic and dichorionic twins.
Linskens IH; Spreeuwenberg MD; Blankenstein MA; van Vugt JM
Prenat Diagn; 2009 Jan; 29(1):74-8. PubMed ID: 19173346
[TBL] [Abstract][Full Text] [Related]
45. Co-variables in first trimester maternal serum screening.
de Graaf IM; Cuckle HS; Pajkrt E; Leschot NJ; Bleker OP; van Lith JM
Prenat Diagn; 2000 Mar; 20(3):186-9. PubMed ID: 10719318
[TBL] [Abstract][Full Text] [Related]
46. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection.
Hui PW; Lam YH; Tang MH; NG EH; Yeung WS; Ho PC
Prenat Diagn; 2005 May; 25(5):390-3. PubMed ID: 15906430
[TBL] [Abstract][Full Text] [Related]
47. Influence of maternal systemic lupus erythematosus on first-trimester combined screening for chromosomal abnormalities.
Heinig J; Steinhard J; Schmitz R; Nofer JR; Kiesel L; Klockenbusch W
Prenat Diagn; 2007 Jul; 27(7):600-2. PubMed ID: 17437322
[TBL] [Abstract][Full Text] [Related]
48. The impact of assisted reproductive technology on the association between first-trimester pregnancy-associated plasma protein a and human chorionic gonadotropin and adverse pregnancy outcomes.
Zhong Y; Bradshaw R; Stanley AP; Odibo AO
Am J Perinatol; 2011 May; 28(5):347-54. PubMed ID: 21082535
[TBL] [Abstract][Full Text] [Related]
49. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
Spencer K; Kagan KO; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):49-52. PubMed ID: 18186136
[TBL] [Abstract][Full Text] [Related]
50. First-trimester maternal serum screening and the risk for fetal distress during labor.
Uccella S; Colombo GF; Bulgheroni CM; Serati M; Bogani G; Salvatore S; Ghezzi F; Bolis P
Am J Obstet Gynecol; 2009 Aug; 201(2):166.e1-6. PubMed ID: 19646567
[TBL] [Abstract][Full Text] [Related]
51. First trimester pregnancy associated plasma protein-A as a marker for poor pregnancy outcome in patients with early-onset fetal growth restriction.
Fox NS; Chasen ST
Prenat Diagn; 2009 Dec; 29(13):1244-8. PubMed ID: 19862778
[TBL] [Abstract][Full Text] [Related]
52. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
[TBL] [Abstract][Full Text] [Related]
53. Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R; Pérez Penco JM; Skyfta E; Rodríguez Calvo J; Nicolaides KH
Fetal Diagn Ther; 2010; 27(2):72-7. PubMed ID: 20332643
[TBL] [Abstract][Full Text] [Related]
54. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA
Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302
[TBL] [Abstract][Full Text] [Related]
55. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
[TBL] [Abstract][Full Text] [Related]
56. First trimester screening for Down syndrome in rhesus negative women.
Muhcu M; Mungen E; Atay V; Ipcioglu OM; Dundar O; Ergur R; Yergok YZ
Prenat Diagn; 2008 May; 28(5):404-7. PubMed ID: 18318000
[TBL] [Abstract][Full Text] [Related]
57. Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10-14 weeks.
Spencer K; Liao AW; Ong CY; Flack NJ; Nicolaides KH
Prenat Diagn; 2001 Jul; 21(7):571-4. PubMed ID: 11494294
[TBL] [Abstract][Full Text] [Related]
58. First-trimester biochemistry and outcomes in twin pregnancy.
Chasen ST; Martinucci S; Perni SC; Kalish RB
J Reprod Med; 2009 May; 54(5):312-4. PubMed ID: 19517696
[TBL] [Abstract][Full Text] [Related]
59. Pregnancy outcomes in unselected singleton pregnant women with an increased risk of first-trimester Down's syndrome.
Liu SS; Lee FK; Lee JL; Tsai MS; Cheong ML; She BQ; Chen SC
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1130-4. PubMed ID: 15548144
[TBL] [Abstract][Full Text] [Related]
60. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Prenat Diagn; 2008 Jan; 28(1):7-10. PubMed ID: 18000943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
